This report summarizes a June 2011 meeting at which experts explored the potential correlation between epigenetic modifications of genomic DNA and the development of hypertension.
Research Meeting Summaries
Filter Research Meeting Summaries
In June 2011, a working group recommended future research to achieve new management approaches for all forms of non-obstructive chronic bronchitis, an inflammatory disease involving excessive secretion in the airways of the lungs.
This report summarizes a June 2011 meeting at which investigators evaluated the current capabilities of available hemostatic global assays and proposed research that could move the field forward.
In June 2011, a working group advised NHLBI about research areas that might be beneficial to explore during a possible continuation of the Coronary Artery Risk Development in Young Adults (CARDIA) Study.
This report summarizes a May 2011 working group meeting at which experts identified and created a compendium of best practices for Data Coordinating Centers (DCC) that support large clinical trial programs.
The NHLBI and the American Association for Thoracic Surgery (AATS) hosted a symposium on April 26, 2011, and a workshop that followed on April 27, 2011, to identify major research opportunities and gaps in collaborative clinical research for cardiothoracic surgery.
This report summarizes a March 2011 meeting at which experts recommended strategies that might encourage the use and standardization of electronic health records in support of cardiopulmonary research.
This report summarizes a February 2011 workshop on the use of controlled hypothermia in treating traumatic injuries and significant blood loss.
In January 2011, a working group met to help guide future research efforts in the area of bariatric surgery and to determine whether the state of the science in this field indicates that larger clinical trials should be conducted.
This report summarizes a January 2011 working group meeting at which experts identified areas and challenges that should be addressed to further the field of cardiovascular pharmacogenomics and increase its use in clinical care.